GlassScriptPhysician profile
Nathan Turner
NPI 1508242595
$11,027.87
in general payments reported to CMS, 2019-2025
35 companies · $2,843 in 2025
The $2,843 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,477 · 2022: $3,120 · 2023: $1,725 · 2024: $1,862 · 2025: $2,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,067 · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,066.64 |
| Travel and Lodging | $363.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,258.66 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Abbvie INC. | $1,726.96 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $1,176.01 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $1,055.43 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Pfizer INC. | $488.80 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $377.38 | 2021-2025 | Relistor |
| Nevro Corp. | $244.31 | 2022-2024 | Senza |
| Biohaven Pharmaceuticals, INC. | $209.75 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $196.03 | 2022 | |
| Horizon Therapeutics Plc | $153.09 | 2021-2022 | |
| Saluda Medical Americas, INC. | $92.72 | 2025 | Evoke |
| Almatica Pharma LLC | $89.16 | 2021-2022 | |
| Relievant Medsystems, INC. | $84.88 | 2023 | Intracept |
| Redhill Biopharma INC. | $76.92 | 2021-2022 | |
| Abbott Laboratories | $74.75 | 2022-2024 | Proclaim, Eterna |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $71.51 | 2024-2025 | Sublocade |
| Allergan, INC. | $65.19 | 2021-2022 | |
| Vertos Medical, INC. | $61.10 | 2023 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $60.51 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $52.75 | 2021 | |
| Merz Pharmaceuticals, LLC | $47.30 | 2021 | |
| Tactile Systems Technology INC | $47.17 | 2025 | Nimbl, Flexitouch Plus |
| Si-Bone, INC. | $45.30 | 2023-2025 | |
| Lilly USA, LLC | $43.09 | 2021-2023 | Emgality, Reyvow |
| Hikma Pharmaceuticals USA | $42.00 | 2022 | |
| Averitas Pharma INC. | $29.79 | 2025 | Qutenza |
| Arbor Pharmaceuticals, INC. | $27.14 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.19 | 2025 | |
| Azurity Pharmaceuticals, INC. | $19.71 | 2023 | Horizant |
| Curonix LLC | $19.15 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lundbeck LLC | $16.29 | 2025 | Vyepti |
| Ethicon US, LLC | $15.65 | 2021 | |
| International Rehabilitative Sciences, INC | $14.82 | 2024 | Rs 4i Plus Sequential Stimulator |
| Ibsa Pharma INC. | $14.79 | 2021 | |
| Grt US Holding, INC. | $8.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.